Cellics Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$7M
- Investors
-
2
Cellics Therapeutics General Information
Description
Developer of nanosponge technology designed to address serious diseases with a high unmet medical need. The company's technology utilizes a nanosponge mechanism for the treatment of animal venoms and rare diseases that are caused by virulent factors due to attacks on red blood cells, enabling physicians to treat their patients in an enhanced way.
Contact Information
Website
www.cellics.comCorporate Office
- 11588 Sorrento Valley Road
- Suite 20
- San Diego, CA 92121
- United States
Corporate Office
- 11588 Sorrento Valley Road
- Suite 20
- San Diego, CA 92121
- United States
Cellics Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B) | 17-Feb-2022 | $7M | Completed | Clinical Trials - Phase 1 | ||
| 5. Grant | 21-Oct-2020 | Completed | Pre-Clinical Trials | |||
| 4. Later Stage VC (Series A3) | 08-Jun-2020 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 20-Apr-2018 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A1) | $2.5M | $8.5M | Completed | Pre-Clinical Trials | ||
| 1. Early Stage VC (Series A) | 21-Apr-2017 | $6M | $6M | Completed | Pre-Clinical Trials |
Cellics Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A3 | ||||||||
| Series A2 | ||||||||
| Series A1 | 1,006,239 | $0.001000 | 8% | $2.48 | $2.48 | 1x | $2.48 | 4.28% |
| Series A | 4,900,000 | $0.001000 | 8% | $1.22 | $1.22 | 1x | $1.22 | 20.83% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cellics Therapeutics Comparisons
Industry
Financing
Details
Cellics Therapeutics Competitors (2)
One of Cellics Therapeutics’s 2 competitors is GentiBio, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GentiBio | Venture Capital-Backed | Cambridge, MA | ||||
| TRexBio | Formerly VC-backed | South San Francisco, CA |
Cellics Therapeutics Patents
Cellics Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019388869-A1 | Nanoparticles containing cellular membrane and uses thereof | Active | 26-Nov-2018 | ||
| AU-2019388869-B2 | Nanoparticles containing cellular membrane and uses thereof | Active | 26-Nov-2018 | ||
| CA-3120860-A1 | Nanoparticles containing cellular membrane and uses thereof | Pending | 26-Nov-2018 | ||
| EP-3886870-A1 | Nanoparticles containing cellular membrane and uses thereof | Pending | 26-Nov-2018 | ||
| EP-3886870-A4 | Nanoparticles containing cellular membrane and uses thereof | Pending | 26-Nov-2018 | A61K9/5068 |
Cellics Therapeutics Signals
Cellics Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CARB-X | University | |||
| CASH Capital | Venture Capital | Minority |
Cellics Therapeutics FAQs
-
When was Cellics Therapeutics founded?
Cellics Therapeutics was founded in 2014.
-
Where is Cellics Therapeutics headquartered?
Cellics Therapeutics is headquartered in San Diego, CA.
-
What is the size of Cellics Therapeutics?
Cellics Therapeutics has 21 total employees.
-
What industry is Cellics Therapeutics in?
Cellics Therapeutics’s primary industry is Drug Discovery.
-
Is Cellics Therapeutics a private or public company?
Cellics Therapeutics is a Private company.
-
What is the current valuation of Cellics Therapeutics?
The current valuation of Cellics Therapeutics is .
-
What is Cellics Therapeutics’s current revenue?
The current revenue for Cellics Therapeutics is .
-
How much funding has Cellics Therapeutics raised over time?
Cellics Therapeutics has raised $25.5M.
-
Who are Cellics Therapeutics’s investors?
CARB-X and CASH Capital have invested in Cellics Therapeutics.
-
Who are Cellics Therapeutics’s competitors?
GentiBio and TRexBio are competitors of Cellics Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process